Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform


2ndary - Private LATEST DEAL TYPE

Developer of innovative immunotherapies intended to treat cancer effectively. The company's innovative immunotherapies is based on the discoveries regarding the role of yo T cell receptors (TCR's) in the broad recognition of hematological and solid tumor cells and their potential use for the treatment of advanced malignancies, enabling healthcare institutions and cancer patients to eradicate both hematological and solid tumors lowering the chances of cancer.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Yalelaan 62
  • 3584 CM Utrecht
  • Netherlands

+31 085 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Gadeta’s full profile, request a free trial.

Gadeta Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 19-Jul-2018 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 29-Mar-2016 00.000 00.000 Completed Startup
1. Seed Round Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Gadeta Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immatics Venture Capital-Backed Tübingen, Germany 000 00000 00000000000 00000
00000000 Formerly VC-backed Munich, Germany 000.00 000000&0 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000000 0000000000 Venture Capital-Backed San Diego, CA 00 00000 00000000
0000000 0000000000 Venture Capital-Backed Philadelphia, PA 0000 00000000000 0000
To view this company’s complete list of competitors, request access »

Gadeta Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Kite Pharma Corporation Majority 000 0000 000000 0
Baxalta Ventures Corporate Venture Capital Minority 000 0000 000000 0
Medicxi Venture Capital Minority 000 0000 000000 0
Utrecht Holdings Venture Capital Minority 000 0000 000000 0

Gadeta Executive Team (5)

Name Title Board
Guido Maertens Chief Financial Officer
Tolleiv Trimborn Ph.D Chief Operations Officer
Jurgen Kuball MD Co-Founder & Scientific Advisor
Shelley Margetson Chief Executive Officer
Mark De Boer Ph.D Co-Founder

Gadeta Board Members (5)

Name Representing Role Since Contact
Giovanni Mariggi Ph.D Medicxi Board Member 000 0000
Michèle Ollier MD Medicxi Board Member 000 0000
Oscar Schoots Ph.D Utrecht Holdings Board Member 000 0000

2 Former Board Members

You’re viewing 3 of 5 board members. Get the full list »